FENNEC PHARMACEUTICALS INC (FENC:NASDAQ)
$9.01 0.16 (1.8079%)
Analysed FENNEC PHARMACEUTICALS INC (FENC:NASDAQ) News Sources
Adherex Technologies Q1 Earnings Call Highlights
14-05-2026
marketbeat.com
Do Options Traders Know Something About Adherex Technologies Stock We Don't?
14-05-2026
yahoo.com
Fennec Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
14-05-2026
moby.co
Fennec Pharmaceuticals Inc (FENC) Q1 2026 Earnings Call Highlights: Record Sales Surge and ...
14-05-2026
yahoo.com
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18-05-2026
yahoo.com
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
21-05-2026
yahoo.com
Fennec Announces New Research Supporting Pedmark's Use at ASCO Annual Meeting
22-05-2026
yahoo.com
Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter
23-05-2026
marketbeat.com
Insider Favorites High Growth Companies June 2026
08-06-2026
yahoo.com
Fennec Announces Results of Annual Meeting
10-06-2026
yahoo.com
What is the current price of FENNEC PHARMACEUTICALS INC (FENC:NASDAQ)?
The current price of FENNEC PHARMACEUTICALS INC (FENC:NASDAQ) is $9.01.
FENNEC PHARMACEUTICALS INC (FENC:NASDAQ) absolute price change since previous trading day?
The absolute price change of FENNEC PHARMACEUTICALS INC (FENC:NASDAQ) since the previous trading day is $0.16.
FENNEC PHARMACEUTICALS INC (FENC:NASDAQ) percentage price change since previous trading day?
The percentage price change of FENNEC PHARMACEUTICALS INC (FENC:NASDAQ) since the previous trading day is 1.8079%.
What is the most recent average sentiment score for FENNEC PHARMACEUTICALS INC (FENC:NASDAQ)?
The most recent average sentiment score for FENNEC PHARMACEUTICALS INC (FENC:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for FENNEC PHARMACEUTICALS INC (FENC:NASDAQ)?
The most recent sentiment for FENNEC PHARMACEUTICALS INC (FENC:NASDAQ) is .
SEC-8K** Filing Available For FENNEC PHARMACEUTICALS INC (FENC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.